1 1184 71 EVALUATION OF YOGA THERAPY PROGRAMME FOR PATIENTS OF BRONCHIAL ASTHMA. A STUDY OF THE EFFECT OF YOGA THERAPY PROGRAMME ON 46 INDOOR PATIENTS OF CHRONIC BRONCHIAL ASTHMA ON EXERCISE CAPACITY, PULMONARY FUNCTIONS AND BLOOD GASES WAS CONDUCTED. EXERCISE CAPACITY WAS MEASURED BY 3 TESTS: (I) 12 MIN WALK TEST (12-MD); (II) PHYSICAL FITNESS INDEX (PFI) BY MODIFIED HARVARD STEP TEST; AND (III) EXERCISE-LIABILITY INDEX (ELI). YOGA THERAPY PROGRAMME RESULTED IN A SIGNIFICANT INCREASE IN THE PULMONARY FUNCTIONS AND EXERCISE TOLERANCE. A ONE-YEAR FOLLOW-UP STUDY SHOWED A GOOD TO FAIR RESPONSE WITH REDUCED SYMPTOMS SCORE AND DRUG REQUIREMENTS IN THESE SUBJECTS. IT IS CONCLUDED THAT YOGA THERAPY IS BENEFICIAL FOR BRONCHIAL ASTHMA. 1993 2 316 18 AN INTEGRATED APPROACH OF YOGA THERAPY FOR BRONCHIAL ASTHMA: A 3-54-MONTH PROSPECTIVE STUDY. AFTER AN INITIAL INTEGRATED YOGA TRAINING PROGRAM OF 2 TO 4 WEEKS, 570 BRONCHIAL ASTHMATICS WERE FOLLOWED UP FOR 3 TO 54 MONTHS. THE TRAINING CONSISTED OF YOGA PRACTICES--YOGASANAS, PRANAYAMA, MEDITATION, AND KRIYAS--AND THEORY OF YOGA. RESULTS SHOW HIGHLY SIGNIFICANT IMPROVEMENT IN MOST OF THE SPECIFIC PARAMETERS. THE REGULAR PRACTITIONERS SHOWED THE GREATEST IMPROVEMENT. PEAK EXPIRATORY FLOW RATE (PFR) VALUES SHOWED SIGNIFICANT MOVEMENT OF PATIENTS TOWARD NORMALCY AFTER YOGA, AND 72, 69, AND 66% OF THE PATIENTS HAVE STOPPED OR REDUCED PARENTERAL, ORAL, AND CORTISONE MEDICATION, RESPECTIVELY. THESE RESULTS ESTABLISH THE LONG-TERM EFFICACY OF THE INTEGRATED APPROACH OF YOGA THERAPY IN THE MANAGEMENT OF BRONCHIAL ASTHMA. 1986 3 879 38 EFFECT OF YOGA TRAINING ON EXERCISE TOLERANCE IN ADOLESCENTS WITH CHILDHOOD ASTHMA. FORTY SIX YOUNG ASTHMATICS WITH A HISTORY OF CHILDHOOD ASTHMA WERE ADMITTED FOR YOGA TRAINING. EFFECTS OF TRAINING ON RESTING PULMONARY FUNCTIONS, EXERCISE CAPACITY, AND EXERCISE-INDUCED BRONCHIAL LABILITY INDEX WERE MEASURED. YOGA TRAINING RESULTED IN A SIGNIFICANT INCREASE IN PULMONARY FUNCTION AND EXERCISE CAPACITY. A FOLLOW-UP STUDY SPANNING TWO YEARS SHOWED A GOOD RESPONSE WITH REDUCED SYMPTOM SCORE AND DRUG REQUIREMENTS IN THESE SUBJECTS. IT IS CONCLUDED THAT YOGA TRAINING IS BENEFICIAL FOR YOUNG ASTHMATICS. 1991 4 2173 19 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 5 1123 24 EFFICACY OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA. THE AIM OF THE STUDY WAS TO TEST THE EFFICACY OF A ONE MONTH IN-PATIENT NATUROPATHY AND YOGA PROGRAMME FOR PATIENTS WITH ASTHMA. RETROSPECTIVE DATA OF 159 BRONCHIAL ASTHMA PATIENTS, UNDERGOING THE NATUROPATHY AND YOGA PROGRAMME, WAS ANALYZED FOR FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME AT THE END OF 1 SECOND, MAXIMUM VOLUNTARY VENTILATION AND PEAK EXPIRATORY FLOW RATE ON ADMISSION, 11TH DAY, ON DISCHARGE AND ONCE IN THREE MONTHS FOR THREE YEARS. THE PAIRED SAMPLE T TEST RESULTS SHOWED SIGNIFICANT INCREASE IN THE FORCED VITAL CAPACITY AND FORCED EXPIRATORY VOLUME FROM THE DATE OF ADMISSION UP TO 6TH MONTH (P < 0.0035) POST BONFERRONI CORRECTION. MAXIMUM VOLUNTARY VENTILATION SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE DATE OF DISCHARGE (P < 0.0035) AND PEAK EXPIRATORY FLOW RATE SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE 36TH MONTH OF FOLLOW-UP (P < 0.0035), POST BONFERRONI CORRECTION. THIS VALIDATED THE BENEFICIAL EFFECT OF COMBINING NATUROPATHY AND YOGA FOR THE MANAGEMENT OF BRONCHIAL ASTHMA. 2014 6 2786 29 YOGA THERAPY AS AN ADJUVANT IN MANAGEMENT OF ASTHMA. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON CONTROL OF ASTHMA IN CHILDREN WITH BRONCHIAL ASTHMA. METHODS: THIS HOSPITAL-BASED INTERVENTIONAL RANDOMIZED CONTROLLED TRIAL CONDUCTED IN THE DEPARTMENT OF PEDIATRICS AT A TERTIARY CARE CENTER OF NORTH INDIA FROM NOVEMBER 2017 TO OCTOBER 2018 ENROLLED 140 NEWLY DIAGNOSED CASES OF ASTHMA OF AGE 10-16 Y WHO WERE RANDOMLY DIVIDED INTO TWO GROUPS. SEVENTY CHILDREN IN THE CASE GROUP PRACTICED YOGA UNDER SUPERVISION FOR A PERIOD OF 3 MO IN ADDITION TO PHARMACOLOGICAL TREATMENT. SEVENTY CONTROLS RECEIVED ONLY PHARMACOLOGICAL TREATMENT. PULMONARY-FUNCTION TESTS WERE DONE AT BASELINE, 6 WK, AND 12 WK ALONG WITH QUALITY OF LIFE (QOL) ASSESSMENT BY PEDIATRIC ASTHMA QUALITY OF LIFE QUESTIONNAIRE (PAQLQ). THE OUTCOME MEASURES ASSESSED WERE FORCED VITAL CAPACITY (FVC), FORCED EXPIRATORY VOLUME IN ONE SECOND (FEV1), FEV1/FVC AND PEAK EXPIRATORY FLOW RATE (PEFR). QOL EVALUATION WAS DONE IN 3 DOMAINS: ACTIVITY LIMITATION, SYMPTOMS, AND EMOTIONAL FUNCTION. RESULTS: THE ASTHMATIC CHILDREN PRACTICING YOGA HAVE SHOWN SIGNIFICANT IMPROVEMENT IN FVC, FEV1, FEV1/FVC AND PEFR WHICH WAS BETTER AS COMPARED TO CONTROLS. IMPROVEMENT WAS ALSO NOTED IN MEAN-PAQLQ SCORE IN CASES WHICH WAS STATISTICALLY SIGNIFICANTLY BETTER AS COMPARED TO CONTROLS. CONCLUSION: YOGA APPEARS TO HAVE SIGNIFICANT POSITIVE EFFECT ON CONTROL OF ASTHMA MEASURED BY PULMONARY-FUNCTION TEST AND QOL. THEREFORE YOGA THERAPY CAN BE RECOMMENDED AS AN ADJUVANT IN MANAGEMENT OF ASTHMA ALONG WITH STANDARD PHARMACOLOGICAL MANAGEMENT. 2021 7 2929 21 [YOGA TO IMPROVE ASTHMA CONTROL IN SEVERE ASTHMATICS TREATED WITH BIOLOGICS]. WE CONDUCTED A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE EFFICACY OF YOGA IN POORLY CONTROLLED SEVERE ASTHMATIC PATIENTS TREATED WITH MAXIMAL INHALED THERAPY AND BIOLOGICS. THE OBJECTIVE OF YOGA WAS TO IMPROVE BREATHING CONSCIOUSNESS, EXERCISING CONTROLLED VENTILATION WITH AND WITHOUT RETENTION, ABDOMINAL BREATHING OBSERVATION, IMPROVEMENT OF INSPIRATORY AND EXPIRATORY MUSCLES, OPENING OF THE CHEST, DIAPHRAGM EXERCISES AND RELAXATION. WE MEASURED EXHALED NITRIC OXIDE, FORCED EXPIRATORY VOLUME IN ONE SECOND, FORCED VITAL CAPACITY, ASTHMA CONTROL AND QUALITY OF LIFE QUESTIONNAIRES, ANXIETY AND DEPRESSION QUESTIONNAIRES BEFORE AND AFTER THE TENTH YOGA COURSE (PERFORMED TWICE A WEEK). HALF OF THE PATIENTS WHO WERE INVITED TO PARTICIPATE TO THE STUDY DECLINED DUE TO ORGANIZATION PROBLEMS. TWO PATIENTS WERE EXCLUDED DUE TO BRONCHITIS AND ARTHRALGIA RESPECTIVELY. THE ANALYSIS OF THE DATA FROM 12 PARTICIPANTS REVEALED SIGNIFICANT IMPROVEMENT IN ASTHMA CONTROL AND ASTHMA QUALITY OF LIFE QUESTIONNAIRES AND A REDUCTION OF ANXIETY.THE REGULAR PRACTICE OF YOGA IN SEVERE ASTHMATICS INSUFFICIENTLY CONTROLLED DESPITE MAXIMAL INHALED TREATMENT AND BIOTHERAPY SEEMS TO BE AN INTERESTING COMPLEMENTARY OPTION TO IMPROVE ASTHMA CONTROL. OUR RESULTS MUST BE CONFIRMED IN LARGER RANDOMIZED CONTROLLED TRIALS. 2020 8 2197 33 THE EFFICACY OF A COMPREHENSIVE LIFESTYLE MODIFICATION PROGRAMME BASED ON YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THERE IS A SUBSTANTIAL BODY OF EVIDENCE ON THE EFFICACY OF YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA. MANY STUDIES HAVE REPORTED, AS THE EFFECTS OF YOGA ON BRONCHIAL ASTHMA, SIGNIFICANT IMPROVEMENTS IN PULMONARY FUNCTIONS, QUALITY OF LIFE AND REDUCTION IN AIRWAY HYPER-REACTIVITY, FREQUENCY OF ATTACKS AND MEDICATION USE. IN ADDITION, A FEW STUDIES HAVE ATTEMPTED TO UNDERSTAND THE EFFECTS OF YOGA ON EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB) OR EXERCISE TOLERANCE CAPACITY. HOWEVER, NONE OF THESE STUDIES HAS INVESTIGATED ANY IMMUNOLOGICAL MECHANISMS BY WHICH YOGA IMPROVES THESE VARIABLES IN BRONCHIAL ASTHMA. METHODS: THE PRESENT RANDOMIZED CONTROLLED TRIAL (RCT) WAS CONDUCTED ON 57 ADULT SUBJECTS WITH MILD OR MODERATE BRONCHIAL ASTHMA WHO WERE ALLOCATED RANDOMLY TO EITHER THE YOGA (INTERVENTION) GROUP (N = 29) OR THE WAIT-LISTED CONTROL GROUP (N = 28). THE CONTROL GROUP RECEIVED ONLY CONVENTIONAL CARE AND THE YOGA GROUP RECEIVED AN INTERVENTION BASED ON YOGA, IN ADDITION TO THE CONVENTIONAL CARE. THE INTERVENTION CONSISTED OF 2-WK SUPERVISED TRAINING IN LIFESTYLE MODIFICATION AND STRESS MANAGEMENT BASED ON YOGA FOLLOWED BY CLOSELY MONITORED CONTINUATION OF THE PRACTICES AT HOME FOR 6-WK. THE OUTCOME MEASURES WERE ASSESSED IN BOTH THE GROUPS AT 0 WK (BASELINE), 2, 4 AND 8 WK BY USING GENERALIZED LINEAR MODEL (GLM) REPEATED MEASURES FOLLOWED BY POST-HOC ANALYSIS. RESULTS: IN THE YOGA GROUP, THERE WAS A STEADY AND PROGRESSIVE IMPROVEMENT IN PULMONARY FUNCTION, THE CHANGE BEING STATISTICALLY SIGNIFICANT IN CASE OF THE FIRST SECOND OF FORCED EXPIRATORY VOLUME (FEV1) AT 8 WK, AND PEAK EXPIRATORY FLOW RATE (PEFR) AT 2, 4 AND 8 WK AS COMPARED TO THE CORRESPONDING BASELINE VALUES. THERE WAS A SIGNIFICANT REDUCTION IN EIB IN THE YOGA GROUP. HOWEVER, THERE WAS NO CORRESPONDING REDUCTION IN THE URINARY PROSTAGLANDIN D2 METABOLITE (11BETA PROSTAGLANDIN F2ALPHA) LEVELS IN RESPONSE TO THE EXERCISE CHALLENGE. THERE WAS ALSO NO SIGNIFICANT CHANGE IN SERUM EOSINOPHILIC CATIONIC PROTEIN LEVELS DURING THE 8-WK STUDY PERIOD IN EITHER GROUP. THERE WAS A SIGNIFICANT IMPROVEMENT IN ASTHMA QUALITY OF LIFE (AQOL) SCORES IN BOTH GROUPS OVER THE 8-WK STUDY PERIOD. BUT THE IMPROVEMENT WAS ACHIEVED EARLIER AND WAS MORE COMPLETE IN THE YOGA GROUP. THE NUMBER-NEEDED-TO-TREAT WORKED OUT TO BE 1.82 FOR THE TOTAL AQOL SCORE. AN IMPROVEMENT IN TOTAL AQOL SCORE WAS GREATER THAN THE MINIMAL IMPORTANT DIFFERENCE AND THE SAME OUTCOME WAS ACHIEVED FOR THE SUB-DOMAINS OF THE AQOL. THE FREQUENCY OF RESCUE MEDICATION USE SHOWED A SIGNIFICANT DECREASE OVER THE STUDY PERIOD IN BOTH THE GROUPS. HOWEVER, THE DECREASE WAS ACHIEVED RELATIVELY EARLIER AND WAS MORE MARKED IN THE YOGA GROUP THAN IN THE CONTROL GROUP. CONCLUSION: THE PRESENT RCT HAS DEMONSTRATED THAT ADDING THE MIND-BODY APPROACH OF YOGA TO THE PREDOMINANTLY PHYSICAL APPROACH OF CONVENTIONAL CARE RESULTS IN MEASURABLE IMPROVEMENT IN SUBJECTIVE AS WELL AS OBJECTIVE OUTCOMES IN BRONCHIAL ASTHMA. THE TRIAL SUPPORTS THE EFFICACY OF YOGA IN THE MANAGEMENT OF BRONCHIAL ASTHMA. HOWEVER, THE PRELIMINARY EFFORTS MADE TOWARDS WORKING OUT THE MECHANISM OF ACTION OF THE INTERVENTION HAVE NOT THROWN MUCH LIGHT ON HOW YOGA WORKS IN BRONCHIAL ASTHMA. TRIAL REGISTRATION: CURRENT CONTROLLED TRIALS ISRCTN00815962. 2009 9 1122 25 EFFICACY OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA--A SELF CONTROLLED MATCHED SCIENTIFIC STUDY. ASTHMA IS ONE OF THE COMMON PSYCHOSOMATIC ILLNESS INFLUENCED BY MANY FACTORS. BRONCHODILATORS GIVE TEMPORARY RELIEF AND HAVE SIDE EFFECTS. THE PRESENT STUDY IS AIMED AT FINDING THE EFFICACY OF A NON-PHARMACOLOGICAL APPROACH OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA. A TOTAL NO OF 37 PATIENTS (19 MEN, 18 WOMEN) WITH MEAN AGE 35.06 YRS (MEN), 40.74 YRS (WOMEN) ADMITTED TO INYS, BANGALORE, FOR THE PERIOD OF 21 DAYS. THE TREATMENT INCLUDED 1. DIET THERAPY 2. NATURE CURE TREATMENT AND 3. YOGA THERAPY. THE VARIOUS PARAMETERS INCLUDING LUNG FUNCTION TEST WERE MEASURED ON ADMISSION AND ONCE A WEEK. RESULTS SHOWED THE SIGNIFICANT IMPROVEMENT IN PEFR, VC, FVC, FEV1, FEV/FEC %, MVV, ESR AND ABSOLUTE EOSINOPHIL COUNT. THE PATIENTS REPORTED A FEELING OF WELL BEING, FRESHNESS AND COMFORTABLE BREATHING. NATUROPATHY AND YOGA HELPS IN INDUCING POSITIVE HEALTH, ALLEVIATING THE SYMPTOMS OF DISEASE BY ACTING AT PHYSICAL AND MENTAL LEVELS. 2001 10 1307 25 HATHA YOGA: IMPROVED VITAL CAPACITY OF COLLEGE STUDENTS. CONTEXT: THE VITAL CAPACITY OF THE LUNGS IS A CRITICAL COMPONENT OF GOOD HEALTH. VITAL CAPACITY IS AN IMPORTANT CONCERN FOR THOSE WITH ASTHMA, HEART CONDITIONS, AND LUNG AILMENTS; THOSE WHO SMOKE; AND THOSE WHO HAVE NO KNOWN LUNG PROBLEMS. OBJECTIVE: TO DETERMINE THE EFFECTS OF YOGA POSTURES AND BREATHING EXERCISES ON VITAL CAPACITY. DESIGN: USING THE SPIROPET SPIROMETER, RESEARCHERS MEASURED VITAL CAPACITY. VITAL CAPACITY DETERMINANTS WERE TAKEN NEAR THE BEGINNING AND END OF TWO 17-WEEK SEMESTERS. NO CONTROL GROUP WAS USED. SETTING: MIDWESTERN UNIVERSITY YOGA CLASSES TAKEN FOR COLLEGE CREDIT. PARTICIPANTS: A TOTAL OF 287 COLLEGE STUDENTS, 89 MEN AND 198 WOMEN. INTERVENTION: SUBJECTS WERE TAUGHT YOGA POSES, BREATHING TECHNIQUES, AND RELAXATION IN TWO 50-MINUTE CLASS MEETINGS FOR 15 WEEKS. MAIN OUTCOME MEASURES: VITAL CAPACITY OVER TIME FOR SMOKERS, ASTHMATICS, AND THOSE WITH NO KNOWN LUNG DISEASE. RESULTS: THE STUDY SHOWED A STATISTICALLY SIGNIFICANT (P < .001) IMPROVEMENT IN VITAL CAPACITY ACROSS ALL CATEGORIES OVER TIME. CONCLUSIONS: IT IS NOT KNOWN WHETHER THESE FINDINGS WERE THE RESULT OF YOGA POSES, BREATHING TECHNIQUES, RELAXATION, OR OTHER ASPECTS OF EXERCISE IN THE SUBJECTS' LIFE. THE SUBJECTS' ADHERENCE TO ATTENDING CLASS WAS 99.96%. THE LARGE NUMBER OF 287 SUBJECTS IS CONSIDERED TO BE A VALID NUMBER FOR A STUDY OF THIS TYPE. THESE FINDINGS ARE CONSISTENT WITH OTHER RESEARCH STUDIES REPORTING THE POSITIVE EFFECT OF YOGA ON THE VITAL CAPACITY OF THE LUNGS. 2000 11 2662 26 YOGA IN BURN: ROLE OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL-THICKNESS CIRCUMFERENTIAL BURNS OF THE CHEST. BACKGROUND: CIRCUMFERENTIAL BURN OF CHEST (CBC) IS A SIGNIFICANT TYPE OF BURN AND CONSIDERS AS A MAJOR CAUSE OF RESTRICTIVE LUNG DISEASE (RLD). PATIENT WHO HAS CBC WITH RLD LEADS TO RESPIRATORY SYMPTOMS SUCH AS BREATHING DIFFICULTY, AIRWAY OBSTRUCTION, REDUCED EXERCISE CAPACITY AND ALTERED PULMONARY FUNCTIONS. HOWEVER, STUDIES EXAMINING THE ROLE OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL THICKNESS CIRCUMFERENTIAL BURN OF CHEST ARE LACKING. OBJECTIVE: TO FIND THE SHORT TERM EFFECTS OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL THICKNESS CIRCUMFERENTIAL BURNS OF CHEST. METHODS: THROUGH SIMPLE RANDOM SAMPLING METHOD THIRTY SUBJECTS (N = 30) WITH RLD FOLLOWING CBC WERE ALLOCATED TO PRANAYAMA BREATHING EXERCISE GROUP (PBE-G; N = 15) AND CONVENTIONAL BREATHING EXERCISE GROUP (CBE-G; N = 15). THEY RECEIVED PRANAYAMA BREATHING EXERCISE AND CONVENTIONAL BREATHING EXERCISE FOR 4 WEEKS RESPECTIVELY. ALL THE SUBJECTS RECEIVED CHEST MOBILITY EXERCISE AS COMMON TREATMENT. PRIMARY (NUMERIC PAIN RATING SCALE - NPRS, FORCED EXPIRATORY VOLUME (FEV1), FORCED VITAL CAPACITY (FVC) AND MAXIMUM VOLUNTARY VENTILATION (MVV) AND SECONDARY (ELECTROMYOGRAM OF STERNOCLEIDOMASTOID, SCALENE, EXTERNAL INTERCOSTAL AND DIAPHRAGM MUSCLE, 6 MIN WALK TEST & GLOBAL RATING OF CHANGE - GRC) OUTCOME MEASURES WERE MEASURED AT BASELINE, AFTER FOUR WEEKS AND AFTER THREE MONTHS FOLLOW UP. RESULTS: BASELINE DEMOGRAPHIC AND CLINICAL VARIABLES SHOW HOMOGENOUS DISTRIBUTION BETWEEN THE GROUPS (P > 0.05). FOUR WEEKS FOLLOWING DIFFERENT BREATHING EXERCISES, PBE-G GROUP SHOWS MORE SIGNIFICANT CHANGES IN PAIN INTENSITY, PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY, EXERCISE TOLERANCE AND GLOBAL RATING OF CHANGE THAN CBE-G GROUP (P 0.05). CONCLUSIONS: YOGA AFFECTS FEV1, 6-MWD, AND QUALITY OF LIFE IN PATIENTS WITH GROUP B COPD. 2019 16 2461 23 YOGA AS A NOVEL ADJUVANT THERAPY FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES. CONTEXT: RECENT STUDIES HAVE DEMONSTRATED THAT PHYSICAL ACTIVITY IS WELL TOLERATED BY PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) AND CAN HAVE ADDITIONAL BENEFITS AS AN ADJUVANT THERAPY TO PHARMACOLOGIC AGENTS, ESPECIALLY IF STARTED EARLY. TO DATE, NO STUDIES HAVE EXAMINED THE EFFECTS OF YOGA ON PATIENTS WITH IIMS. AIMS: THE AIM OF THIS STUDY WAS TO EVALUATE THE EFFECTS OF YOGA ON SELF-REPORTED DIFFICULTY IN PERFORMING ACTIVITIES OF DAILY LIVING (ADL) AND MUSCLE STRENGTH IN PATIENTS WITH MILD-TO-MODERATE IIMS. SUBJECTS AND METHODS: A LONGITUDINAL COHORT STUDY IN WHICH PARTICIPANTS WERE ASSESSED USING THE MYOSITIS ACTIVITIES PROFILE (MAP) AND MANUAL MUSCLE TESTING (MMT) BEFORE AND AFTER THE COMPLETION OF AN 8-WEEK INSTRUCTOR-GUIDED YOGA COURSE WAS PERFORMED. STATISTICAL ANALYSIS USED: WILCOXON SIGNED-RANKED TEST WAS PERFORMED FOR STATISTICAL ANALYSIS. RESULTS: THE AVERAGE POSTTREATMENT MAP SCORES OF SIX PARTICIPANTS DEMONSTRATED AN INCREASE OF 2.51 POINTS, WHILE THE AVERAGE MMT SCORE OF FOUR PARTICIPANTS DEMONSTRATED AN INCREASE OF 11 POINTS. CONCLUSIONS: THIS STUDY IS THE FIRST STUDY TO DATE TO EXAMINE THE EFFECT OF YOGA AS AN ADJUVANT COMPLEMENTARY THERAPY FOR PATIENTS WITH IIM. CONTINUED RESEARCH SHOULD BE DONE ON THE EFFECT OF YOGA AS AN ADJUVANT THERAPY, FOR IN ADDITION TO INCREASE IN MUSCLE STRENGTH AND ABILITY TO PERFORM ADL, YOGA MAY OFFER POTENTIAL IMPROVEMENTS IN MOOD, MENTAL HEALTH, AND SLEEP. 2021 17 286 20 ADJUNCT TREATMENT WITH YOGA IN CHRONIC SEVERE AIRWAYS OBSTRUCTION. ELEVEN PATIENTS WITH SEVERE CHRONIC AIRWAYS OBSTRUCTION WERE GIVEN TRAINING IN YOGIC BREATHING EXERCISES AND POSTURES. A MATCHED GROUP OF 11 PATIENTS WERE GIVEN PHYSIOTHERAPY BREATHING EXERCISES. BOTH GROUPS OF PATIENTS WERE FOLLOWED UP AT MONTHLY INTERVALS FOR NINE MONTHS WITH PULMONARY FUNCTION TESTS, TESTS OF EXERCISE TOLERANCE, AND INQUIRY INTO THEIR SYMPTOMS. AFTER TRAINING IN YOGA THE MEAN MAXIMUM WORK INCREASED SIGNIFICANTLY BY 60.55 KPM; WHEREAS NO SUCH RISE OCCURRED AFTER TRAINING IN PHYSIOTHERAPY. THIS OBJECTIVE IMPROVEMENT WAS ASSOCIATED WITH SYMPTOMATIC IMPROVEMENT IN A SIGNIFICANTLY HIGHER NUMBER OF PATIENTS GIVEN TRAINING IN YOGA. 1978 18 2900 16 [ELEMENTS OF YOGA THERAPY IN THE COMBINED REHABILITATION OF MYOCARDIAL INFARCT PATIENTS IN THE FUNCTIONAL RECOVERY PERIOD]. FIFTY-NINE POSTMYOCARDIAL INFARCTION PATIENTS RECEIVED COMBINED THERAPY INVOLVING CHEMOTHERAPY, PHYSIOTHERAPY, THERAPEUTIC EXERCISES AND YOGA THERAPY. THIRTY-SEVEN CONTROLS RECEIVED THE SAME TREATMENT WITHOUT YOGA EXERCISE. THE YOGA COMPLEX IMPLIED ELEMENTARY SIMPLE POSITIONS, RELAXATION EXERCISE AND RESPIRATORY EXERCISE. A CLINICAL RESPONSE EVIDENT IN BOTH THE GROUPS APPEARED MORE PRONOUNCED IN THE TEST GROUP AS SHOWN BY MARKED IMPROVEMENT IN EXTERNAL RESPIRATION AND BLOOD COUNTS, IN EXERCISE TOLERANCE AND PSYCHOSOMATIC CONDITION OF THE PATIENTS. 1993 19 2547 21 YOGA FOR BRONCHIAL ASTHMA: A CONTROLLED STUDY. FIFTY THREE PATIENTS WITH ASTHMA UNDERWENT TRAINING FOR TWO WEEKS IN AN INTEGRATED SET OF YOGA EXERCISES, INCLUDING BREATHING EXERCISES, SURYANAMASKAR, YOGASANA (PHYSICAL POSTURES), PRANAYAMA (BREATH SLOWING TECHNIQUES), DHYANA (MEDITATION), AND A DEVOTIONAL SESSION, AND WERE TOLD TO PRACTISE THESE EXERCISES FOR 65 MINUTES DAILY. THEY WERE THEN COMPARED WITH A CONTROL GROUP OF 53 PATIENTS WITH ASTHMA MATCHED FOR AGE, SEX, AND TYPE AND SEVERITY OF ASTHMA, WHO CONTINUED TO TAKE THEIR USUAL DRUGS. THERE WAS A SIGNIFICANTLY GREATER IMPROVEMENT IN THE GROUP WHO PRACTISED YOGA IN THE WEEKLY NUMBER OF ATTACKS OF ASTHMA, SCORES FOR DRUG TREATMENT, AND PEAK FLOW RATE. THIS STUDY SHOWS THE EFFICACY OF YOGA IN THE LONG TERM MANAGEMENT OF BRONCHIAL ASTHMA, BUT THE PHYSIOLOGICAL BASIS FOR THIS BENEFICIAL EFFECT NEEDS TO BE EXAMINED IN MORE DETAIL. 1985 20 787 21 EFFECT OF YOGA BREATHING EXERCISES (PRANAYAMA) ON AIRWAY REACTIVITY IN SUBJECTS WITH ASTHMA. THE EFFECTS OF TWO PRANAYAMA YOGA BREATHING EXERCISES ON AIRWAY REACTIVITY, AIRWAY CALIBRE, SYMPTOM SCORES, AND MEDICATION USE IN PATIENTS WITH MILD ASTHMA WERE ASSESSED IN A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL. AFTER BASELINE ASSESSMENT OVER 1 WEEK, 18 PATIENTS WITH MILD ASTHMA PRACTISED SLOW DEEP BREATHING FOR 15 MIN TWICE A DAY FOR TWO CONSECUTIVE 2-WEEK PERIODS. DURING THE ACTIVE PERIOD, SUBJECTS WERE ASKED TO BREATHE THROUGH A PINK CITY LUNG (PCL) EXERCISER--A DEVICE WHICH IMPOSES SLOWING OF BREATHING AND A 1:2 INSPIRATION:EXPIRATION DURATION RATIO EQUIVALENT TO PRANAYAMA BREATHING METHODS; DURING THE CONTROL PERIOD, SUBJECTS BREATHED THROUGH A MATCHED PLACEBO DEVICE. MEAN FORCED EXPIRATORY VOLUME IN 1 S (FEV1), PEAK EXPIRATORY FLOW RATE, SYMPTOM SCORE, AND INHALER USE OVER THE LAST 3 DAYS OF EACH TREATMENT PERIOD WERE ASSESSED IN COMPARISON WITH THE BASELINE ASSESSMENT PERIOD; ALL IMPROVED MORE WITH THE PCL EXERCISER THAN WITH THE PLACEBO DEVICE, BUT THE DIFFERENCES WERE NOT SIGNIFICANT. THERE WAS A STATISTICALLY SIGNIFICANT INCREASE IN THE DOSE OF HISTAMINE NEEDED TO PROVOKE A 20% REDUCTION IN FEV1 (PD20) DURING PRANAYAMA BREATHING BUT NOT WITH THE PLACEBO DEVICE. THE USEFULNESS OF CONTROLLED VENTILATION EXERCISES IN THE CONTROL OF ASTHMA SHOULD BE FURTHER INVESTIGATED. 1990